Seeing Is Believing

Currently out of the existing stock ratings of Sarah James, 118 are a HOLD (25.65%), 329 are a BUY (71.52%), 13 are a SELL (2.83%).
Analyst Sarah James, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 63.88% that have a potential upside of 25.82% achieved within 302 days.
Sarah James’s has documented 916 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SGRY, Surgery Partners at 11-Aug-2026.
Analyst best performing recommendations are on CYH (COMMUNITY HEALTH SYSTEMS).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/12/2024. The price target of $11 was fulfilled within 8 days with a profit of $2.62 (31.26%) receiving and performance score of 39.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jul-2025
$67
$-0.47 (-0.70%)
$60
Buy Since 26-Oct-2017
$79
$11.53 (17.09%)
$36
Hold Since 30-May-2024
$66
$-1.47 (-2.18%)
$28
Buy Since 29-Apr-2026
$80
$12.53 (18.57%)
$75
Hold Since 31-Oct-2025
$65
$-2.47 (-3.66%)
$47
Which stock is Sarah James is most bullish on?
Which stock is Sarah James is most reserved on?
What Year was the first public recommendation made by Sarah James?